Beckley Psytech Limited announced that it has received $40 million in a round of funding on January 4, 2024. The transaction included participation from new investor Atai Life Sciences N.V.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | +1.46% | -10.57% | +23.05% |
May. 15 | Atai Life Sciences N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Atai Life Sciences N.V. Announces CEO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.05% | 286M | |
+40.55% | 50.93B | |
-0.29% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.02% | 26.02B | |
-21.58% | 18.9B | |
+7.44% | 13.21B | |
+24.71% | 12.17B | |
+30.01% | 12.16B |
- Stock Market
- Equities
- ATAI Stock
- News Atai Life Sciences N.V.
- Beckley Psytech Limited announced that it has received $40 million in funding from Atai Life Sciences N.V.